John A. Mccoy Jr. - 27 Feb 2026 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Mar 2026, 19:55:24 UTC
Prior SEC filing
26 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John A. McCoy, Jr. by Jessica H. Paik, Attorney-in-Fact

Key filing fact

John A. Mccoy Jr. filed Form 4 for ABBOTT LABORATORIES (ABT) on 03 Mar 2026.

Key facts

  • This page summarizes John A. Mccoy Jr.'s Form 4 filing for ABBOTT LABORATORIES (ABT).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Mar 2026, 19:55.

Change

  • Previous filing in this sequence was filed on 26 Feb 2026.
  • Current net transaction value: -$200,383.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001644207 Primary reporting owner

MCCOY JOHN A. JR.

Relationship
VICE PRESIDENT AND CONTROLLER
Address
100 ABBOTT PARK ROAD, ABBOTT PARK
Signature
/s/ John A. McCoy, Jr. by Jessica H. Paik, Attorney-in-Fact
Signature date
03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABT transaction

Common shares without par value

Tax liability

Transaction value
$132,769
Shares
-1,142
Change %
-4.3%
Price
$116.26
Shares after
25,213
Date
27 Feb 2026
Ownership
Direct
ABT transaction

Common shares without par value

Sale

Transaction value
$67,614
Shares
-585
Change %
-2.3%
Price
$115.58
Shares after
24,628
Date
02 Mar 2026
Ownership
Direct
ABT holding

Common shares without par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
58
Date
27 Feb 2026
Ownership
Profit Sharing Trust
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .